Article Text

PDF
Is ▼sibutramine more than a slim hope?

Abstract

&#9660Sibutramine* (Reductil - Abbott Laboratories), an orally active monoamine re-uptake inhibitor, is marketed in the UK for treating overweight adults. The company claims that it "helps obese patients control their eating". Is the drug worth prescribing?

Statistics from Altmetric.com

  • Relevant BNF section: 4.5.2

View Full Text

Footnotes

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.